NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

[1]  B. Jeanrenaud.  Insulin, corticosterone and the autonomic nervous system in animal obesities: a viewpoint , 1995, Diabetologia.

[2]  L. Groop,et al.  Insulin resistance, hypertension and microalbuminuria in patients with Type 2 (non-insulin-dependent) diabetes mellitus , 1993, Diabetologia.

[3]  H. Keen,et al.  Coronary heart disease and urinary albumin excretion rate in Type 2 (non-insulin-dependent) diabetic patients , 1988, Diabetologia.

[4]  A. Jonsson,et al.  Blood glycoprotein levels in diabetes mellitus , 1976, Diabetologia.

[5]  C. Osmond,et al.  Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth , 2004, Diabetologia.

[6]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[7]  J. Pickup,et al.  Plasma sialic acid in animal models of diabetes mellitus: evidence for modulation of sialic acid concentrations by insulin deficiency. , 1995, Life sciences.

[8]  J. Pickup,et al.  Serum Sialic Acid Concentration and Coronary Heart Disease in NIDDM , 1995, Diabetes Care.

[9]  J. Yudkin.  Coronary heart disease in diabetes mellitus: three new risk factors and a unifying hypothesis , 1995, Journal of internal medicine.

[10]  J. Robotham,et al.  The acute-phase response. , 1995, New horizons.

[11]  A. Blum.  [Immunological mechanisms in atherosclerosis]. , 1994, Harefuah.

[12]  B. Spiegelman,et al.  Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link , 1994, Diabetes.

[13]  A. Rabinovitch.  Immunoregulatory and Cytokine Imbalances in the Pathogenesis of IDDM: Therapeutic Intervention by Immunostimulation? , 1994, Diabetes.

[14]  B. Wajchenberg,et al.  Syndrome X: a syndrome of insulin resistance. Epidemiological and clinical evidence. , 1994, Diabetes/metabolism reviews.

[15]  A. Whitehead,et al.  The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. , 1994, Immunology today.

[16]  M. Suthanthiran,et al.  Advanced glycosylation endproduct-specific receptors on human and rat T- lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling , 1993, The Journal of experimental medicine.

[17]  J. Pickup,et al.  Serum sialic acid and acute phase proteins in type 1 and type 2 diabetes mellitus. , 1993, Clinica chimica acta; international journal of clinical chemistry.

[18]  J. Stuart,et al.  Effect of patient age on tests of the acute-phase response. , 1993, Archives of pathology & laboratory medicine.

[19]  C. Franceschi,et al.  Increased cytokine production in mononuclear cells of healthy elderly people , 1993, European journal of immunology.

[20]  Heinz Baumann,et al.  Acute Phase Proteins Molecular Biology, Biochemistry, and Clinical Applications , 1993 .

[21]  J. Pickup,et al.  Serum sialic acid enzymatic assay based on microtitre plates: application for measuring capillary serum sialic acid concentrations. , 1993, British journal of biomedical science.

[22]  A. Fernandez-cruz,et al.  Plasma C3d Levels and Ischemic Heart Disease in Type II Diabetes , 1993, Diabetes Care.

[23]  V. Cabana,et al.  The acute‐phase response and associated lipoprotein abnormalities accompanying lymphoma , 1993, Journal of internal medicine.

[24]  J. Pickup,et al.  Elevated Serum Sialic Acid Concentration in NIDDM and Its Relationship to Blood Pressure and Retinopathy , 1993, Diabetes Care.

[25]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[26]  D. Brindley.  Neuroendocrine regulation and obesity. , 1992, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[27]  K. Feingold,et al.  Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. , 1992, Journal of lipid research.

[28]  E. Barrett-Connor.  Lower Endogenous Androgen Levels and Dyslipidemia in Men with Non-Insulin-Dependent Diabetes Mellitus , 1992, Annals of Internal Medicine.

[29]  O. Ganda,et al.  Hyperfibrinogenemia: An important risk factor for vascular complications in diabetes , 1992, Diabetes Care.

[30]  K. Feingold,et al.  Role of Cytokines in Inducing Hyperlipidemia , 1992, Diabetes.

[31]  H. Baumann,et al.  Insulin is a prominent modulator of the cytokine-stimulated expression of acute-phase plasma protein genes. , 1992, Molecular and cellular biology.

[32]  D. Thompson,et al.  Insulin modulation of acute-phase protein production in a human hepatoma cell line. , 1991, Cytokine.

[33]  R. Kisilevsky.  Serum amyloid A (SAA), a protein without a function: some suggestions with reference to cholesterol metabolism. , 1991, Medical hypotheses.

[34]  A. Olsson.  Non-atherosclerotic disease and lipoproteins , 1991 .

[35]  M. Jäättelä.  Biologic activities and mechanisms of action of tumor necrosis factor-alpha/cachectin. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[36]  D E McMillan,et al.  Increased levels of acute-phase serum proteins in diabetes. , 1989, Metabolism: clinical and experimental.

[37]  E. Bonora,et al.  Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. , 1989, The New England journal of medicine.

[38]  S. Sabesin,et al.  Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins. , 1989, Journal of lipid research.

[39]  K. Bendtzen,et al.  Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group. , 1989, Lymphokine research.

[40]  N. Kaplan.  The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. , 1989, Archives of internal medicine.

[41]  G. Reaven.  Role of Insulin Resistance in Human Disease , 1988, Diabetes.

[42]  K. Manogue,et al.  Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. , 1988, Science.

[43]  I. Kushner.  [35] The acute phase response: An overview , 1988 .

[44]  I. Kushner,et al.  The acute phase response: an overview. , 1988, Methods in enzymology.

[45]  C. Avnstorp,et al.  Interleukin‐1 , 1987 .

[46]  G. Viberti,et al.  Microalbuminuria Predicts Mortality in Noninsulin‐dependent Diabetes , 1984, Diabetic medicine : a journal of the British Diabetic Association.

[47]  W. Vale,et al.  Influence of corticotropin-releasing factor on reproductive functions in the rat. , 1984, Endocrinology.

[48]  C. Mogensen,et al.  Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. , 1984, The New England journal of medicine.

[49]  B. Edwards,et al.  Plasma lipid alterations in leukemia and lymphoma. , 1982, The American journal of medicine.

[50]  Y. Uchida,et al.  A new enzymatic method for the determination of sialic acid in serum and its application for a marker of acute phase reactants. , 1981, The Kobe journal of medical sciences.

[51]  J. Stuart,et al.  Haematological stress syndrome in atherosclerosis. , 1981, Journal of clinical pathology.

[52]  C. Schengrund,et al.  Circulating Sialyl Compounds , 1976 .

[53]  H. Blackburn,et al.  Cardiovascular survey methods. , 1969, Monograph series. World Health Organization.

[54]  H. Keen,et al.  AN IMMUNOASSAY METHOD FOR URINARY ALBUMIN AT LOW CONCENTRATIONS. , 1963, Lancet.

[55]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.